Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study (Q44305173)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

restless legs syndrome

1 reference

based on heuristic

inferred from title

7

object named as

Ralf Kohnen

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

object named as

Heike Benes

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Magdolna Hornyak

10

object named as

Magdolna Hornyak

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Wolfgang Mattern

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ines Peglau

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Tillmann Dreykluft

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lars Bergmann

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Corinna Hansen

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Norbert Banik

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

S W Schoen

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

28 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

258

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1046-1054

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-010-5879-7

0 references

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

RLS epidemiology--frequencies, risk factors and methods in population studies

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Evaluating the quality of life of patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless legs syndrome prevalence and impact: REST general population study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Assessing health-related quality of life in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Sleep disorders and depressive feelings: a global survey with the Beck depression scale

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

The association of depression and anxiety with medical symptom burden in patients with chronic medical illness

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless legs syndrome as side effect of second generation antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless legs syndrome, periodic limb movements, and psychopharmacology

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Measuring depression: comparison and integration of three scales in the GENDEP study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Psychometric properties of the Medical Outcomes Study Sleep measure

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome, periodic limb movements in sleep, and depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole in treatment-resistant depression: a 16-week pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining remission on the Montgomery-Asberg depression rating scale.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-010-5879-7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44305173&oldid=2199359738"